Liver and Gastrointestinal Transplant Division, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
Liver and Gastrointestinal Transplant Division, Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
Transplant Proc. 2022 Jun;54(5):1329-1332. doi: 10.1016/j.transproceed.2022.03.033. Epub 2022 Jun 9.
The number of elderly patients who have end-stage liver disease and require liver transplantation has dramatically increased. On the other hand, liver grafts from elderly donors have been offered more frequently for transplantation. The present study aims to analyze the results of liver transplants performed with donors and recipients aged ≥70 years.
We performed a single-center retrospective study of deceased donors liver transplants that involved recipients aged ≥7070 years or recipients who received grafts from donors aged ≥70 years from 2011 to 2021. A literature review on the results of liver transplantation in elderly recipients was also performed.
Thirty septuagenarian recipients were included; their overall 1- and 5-years survival was 80% and 76.6%, respectively. The prevalence of recipients aged ≥70 years in our department was 2.65%. Twenty recipients received grafts form septuagenarian donors; their overall 1- and 5-years survival was 75%. The prevalence of donors aged ≥70 years in our department was 1%. In the literature review, 17 articles were analyzed. The 5-years survival of recipients aged ≥70 years ranged from 47.1% to 78.5%.
Septuagenarian recipients and patients who received grafts from elderly brain-dead donors present adequate overall survival after liver transplantation. Optimized donor-recipient matching is paramount for achieving good outcomes. The combination of high-risk donors with septuagenarian recipients should be avoided as well as using grafts of elderly donors that present others risk factors. Thus, the age of the donor or recipient alone cannot be considered an absolute contraindication for liver transplantation.
需要肝移植的终末期肝病老年患者数量显著增加。另一方面,老年供体的肝移植物被更频繁地用于移植。本研究旨在分析≥70 岁供体和受者进行肝移植的结果。
我们对 2011 年至 2021 年期间≥70 岁的受者或接受≥70 岁供体移植的受者进行了一项单中心回顾性研究。还对老年受者肝移植结果的文献进行了综述。
纳入 30 名 70 岁受者;他们的总体 1 年和 5 年生存率分别为 80%和 76.6%。我们科室≥70 岁受者的患病率为 2.65%。20 名受者接受了 70 岁供者的移植物;他们的总体 1 年和 5 年生存率分别为 75%。我们科室≥70 岁供者的患病率为 1%。在文献综述中,分析了 17 篇文章。≥70 岁受者的 5 年生存率为 47.1%至 78.5%。
70 岁受者和接受脑死亡老年供者移植物的患者在肝移植后具有足够的总体生存率。优化供受者匹配对于获得良好的结果至关重要。应避免将高危供体与 70 岁受者结合使用,也应避免使用存在其他风险因素的老年供体的移植物。因此,供体或受者的年龄本身不能被视为肝移植的绝对禁忌证。